Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
BRD4 promotes endodermal cell fate during mammalian lung development
Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank
Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank
View: Text | PDF
Research Article Development Pulmonology

BRD4 promotes endodermal cell fate during mammalian lung development

  • Text
  • PDF
Abstract

Lung development relies on diverse cell intrinsic and extrinsic mechanisms to ensure proper cellular differentiation and compartmentalization. In addition, it requires precise integration of multiple signaling pathways to temporally regulate morphogenesis and appropriate cell specification. To accomplish this, organogenesis relies on epigenetic and transcriptional regulators to promote cell fate and inhibit alternative cell fates. Using genetic mouse and human embryonic stem cell (hESC) differentiation models, tissue explants, and single-cell transcriptomic analysis, we demonstrated that Bromodomain Containing Protein 4 (BRD4) is required for mammalian lung morphogenesis and cell fate. Endodermal deletion of BRD4 impaired epithelial-mesenchymal crosstalk, leading to disrupted proximal-distal patterning and branching morphogenesis. Moreover, temporal deletion of BRD4 revealed developmental stage–specific defects in airway and alveolar epithelial cell specification with a predominant role in proximal airway cell fate. Similarly, BRD4 promoted lung endodermal cell differentiation into airway lineages in a hESC-derived lung organoid model. Together, these data demonstrate that BRD4 orchestrates early lung morphogenesis and separately regulates cell specification, indicating a multifunctional and evolutionarily conserved role for BRD4 in mammalian lung development.

Authors

Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank

×

Figure 2

Loss of endodermal BRD4 disrupts epithelial-mesenchymal crosstalk.

Options: View larger image (or click on image) Download as PowerPoint
Loss of endodermal BRD4 disrupts epithelial-mesenchymal crosstalk.
(A an...
(A and B) Wholemount IHC for SOX2 and SOX9 to assess branching at E12.5. Scale bar: 200 μm. Quantification data are represented as mean ± SEM. Two-tailed t test: **P ≤ 0.01, n = 3. (C) Left: bright-field images of control and mutant lungs at E12.5. Scale bar: 500 μm. Middle: wholemount IHC for SOX2 and SOX9 after 3 days of culture ex vivo. Scale bar: 500 μm. Dashed white boxes indicate branching tips in control and mutant lungs. Right: magnified images of branching tips. Dashed white lines outline a distal airway. Scale bar: 100 μm. (D) Wholemount IHC for SOX2 and SOX9 at E15.5. Scale bar: 500 μm. Dashed white boxes mark magnified areas shown in the right panels. Scale bar: 100 μm. (E) RNA FISH for Shh, Bmp4, and Fgf10 in control and mutant E12.5 lungs. Scale bar: 50 μm. (F) Matrix plots of differentially expressed genes by RNA-seq of E12.5 epithelium including cell markers, BMP signaling targets, and FGF signaling targets. Genes in red for BMP and FGF targets are positively correlated with activation of each respective signaling pathway. (G) Gene expression analysis by qPCR for Fgf10 (left box) and SHH target genes in E12.5 mesenchyme. Quantification data are represented as mean ± SEM. One-way ANOVA: *P ≤ 0.05, n = 3–4.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts